SYDNEY Australia 23 April 2019: The Board of Imugene Limited (ASX: IMU) is pleased to announce the appointment of a leading global pharmaceutical executive Dr. Lesley Russell as a Non-Executive Director, effective 23 April 2019.
Dr. Lesley Russell has more than 25 years of international operational and leadership experience with a number of established and emerging pharmaceutical companies across multiple therapeutic areas including oncology and haematology.
For further information please download PDF attached:
Download this document
